Zhong Ji Exits Three China JVs, Unit Signs Stem Cell Promotion Deal; Shares Surge 12%

MT Newswires Live

03 Jul

Zhong Ji Longevity Science Group (HKG:0767) said it has agreed to dissolve three joint ventures in mainland China amid shifting market conditions, according to a Hong Kong bourse filing released Wednesday.

Shares of the company soared 12% in Thursday morning trade.

The three joint ventures set up between February and November 2024 aimed to explore biomedical trading, chronic disease treatment technologies, and longevity health services.

All were either non-operational or have ceased operations, the company said, adding that the dissolutions were mutually agreed upon with counterparties and would not materially impact its financials.

In a separate disclosure, the group said its unit Zhongli (Hainan) Life Science Technology on July 2 signed a deal with Beijing Sanyouli Heze Biotechnology to jointly advance a dental pulp stem cell injection therapy for periodontitis in the Boao Lecheng International Medical Tourism Pilot Zone in Hainan, China.

Zhongli will act as the designated promoter of the therapy, handling publicity, commercialization, and global market expansion alongside Beijing Sanyouli and its partners.

Beijing Sanyouli, which specializes in stem cell R&D, has completed Phase I clinical trials of the treatment, according to the filing.

Zhong Ji said the collaboration aligns with its goal of building a life sciences platform and expanding in longevity diagnostics and health services.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2548082913"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2548082913\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2548082913?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-07-03 12:39","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2548082913","market":"hk","top_or_hot":-1,"title":"Zhong Ji Exits Three China JVs, Unit Signs Stem Cell Promotion Deal; Shares Surge 12%","media":"MT Newswires Live","content":"<html><body><p> Zhong Ji Longevity Science Group (HKG:0767) said it has agreed to dissolve three joint ventures in mainland China amid shifting market conditions, according to a <a href=\"https://laohu8.com/S/HKRHF\">Hong Kong</a> bourse filing released Wednesday.</p><p>Shares of the company soared 12% in Thursday morning trade.</p><p>The three joint ventures set up between February and November 2024 aimed to explore biomedical trading, chronic disease treatment technologies, and longevity health services.</p><p>All were either non-operational or have ceased operations, the company said, adding that the dissolutions were mutually agreed upon with counterparties and would not materially impact its financials.</p><p>In a separate disclosure, the group said its unit Zhongli (Hainan) Life Science Technology on July 2 signed a deal with Beijing Sanyouli Heze Biotechnology to jointly advance a dental pulp stem cell injection therapy for periodontitis in the Boao Lecheng International Medical Tourism Pilot Zone in Hainan, China.</p><p>Zhongli will act as the designated promoter of the therapy, handling publicity, commercialization, and global market expansion alongside Beijing Sanyouli and its partners.</p><p>Beijing Sanyouli, which specializes in stem cell R&amp;D, has completed Phase I clinical trials of the treatment, according to the filing.</p><p>Zhong Ji said the collaboration aligns with its goal of building a life sciences platform and expanding in longevity diagnostics and health services.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Zhong Ji Exits Three China JVs, Unit Signs Stem Cell Promotion Deal; Shares Surge 12%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nZhong Ji Exits Three China JVs, Unit Signs Stem Cell Promotion Deal; Shares Surge 12%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-07-03 12:39</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Zhong Ji Longevity Science Group (HKG:0767) said it has agreed to dissolve three joint ventures in mainland China amid shifting market conditions, according to a <a href=\"https://laohu8.com/S/HKRHF\">Hong Kong</a> bourse filing released Wednesday.</p><p>Shares of the company soared 12% in Thursday morning trade.</p><p>The three joint ventures set up between February and November 2024 aimed to explore biomedical trading, chronic disease treatment technologies, and longevity health services.</p><p>All were either non-operational or have ceased operations, the company said, adding that the dissolutions were mutually agreed upon with counterparties and would not materially impact its financials.</p><p>In a separate disclosure, the group said its unit Zhongli (Hainan) Life Science Technology on July 2 signed a deal with Beijing Sanyouli Heze Biotechnology to jointly advance a dental pulp stem cell injection therapy for periodontitis in the Boao Lecheng International Medical Tourism Pilot Zone in Hainan, China.</p><p>Zhongli will act as the designated promoter of the therapy, handling publicity, commercialization, and global market expansion alongside Beijing Sanyouli and its partners.</p><p>Beijing Sanyouli, which specializes in stem cell R&amp;D, has completed Phase I clinical trials of the treatment, according to the filing.</p><p>Zhong Ji said the collaboration aligns with its goal of building a life sciences platform and expanding in longevity diagnostics and health services.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"00767","symbol_name":"中基长寿科学","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2548082913","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2548082913","pubTimestamp":1751517595,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Zhong Ji Longevity Science Group  said it has agreed to dissolve three joint ventures in mainland China amid shifting market conditions, according to a Hong Kong bourse filing released Wednesday.Shares of the company soared 12% in Thursday morning trade.The three joint ventures set up between February and November 2024 aimed to explore biomedical trading, chronic disease treatment technologies, and longevity health services.All were either non-operational or have ceased operations, the company said, adding that the dissolutions were mutually agreed upon with counterparties and would not materially impact its financials.In a separate disclosure, the group said its unit Zhongli  Life Science Technology on July 2 signed a deal with Beijing Sanyouli Heze Biotechnology to jointly advance a dental pulp stem cell injection therapy for periodontitis in the Boao Lecheng International Medical Tourism Pilot Zone in Hainan, China.Zhongli will act as the designated promoter of the therapy, handling","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"00767":"中基长寿科学","BK1186":"特殊金融服务"},"translate_title":"中基退出三家中国合资企业，单位签署干细胞推广协议；股价飙升12%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"00767":0.9},"content_text":"Zhong Ji Longevity Science Group (HKG:0767) said it has agreed to dissolve three joint ventures in mainland China amid shifting market conditions, according to a Hong Kong bourse filing released Wednesday.Shares of the company soared 12% in Thursday morning trade.The three joint ventures set up between February and November 2024 aimed to explore biomedical trading, chronic disease treatment technologies, and longevity health services.All were either non-operational or have ceased operations, the company said, adding that the dissolutions were mutually agreed upon with counterparties and would not materially impact its financials.In a separate disclosure, the group said its unit Zhongli (Hainan) Life Science Technology on July 2 signed a deal with Beijing Sanyouli Heze Biotechnology to jointly advance a dental pulp stem cell injection therapy for periodontitis in the Boao Lecheng International Medical Tourism Pilot Zone in Hainan, China.Zhongli will act as the designated promoter of the therapy, handling publicity, commercialization, and global market expansion alongside Beijing Sanyouli and its partners.Beijing Sanyouli, which specializes in stem cell R&D, has completed Phase I clinical trials of the treatment, according to the filing.Zhong Ji said the collaboration aligns with its goal of building a life sciences platform and expanding in longevity diagnostics and health services.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":0,"code":"91000000","status":"200"}}}